Celltrion
068270.KS
$130.84
Share price
-0.11%
Change (1 day)
4.46%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Celltrion (068270.KS) - Total debt
Total debt on the balance sheet as of December 2023 : $1.46 B
According to Celltrion 's latest financial reports the company's total debt is $1.46 B. A company’s total debt is the sum of all current and non-current debts.
Celltrion - Total debt on balance sheet (from 2007 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $0.62 B | 0.45% |
| 2021-12-31 | $0.62 B | -12.24% |
| 2020-12-31 | $0.71 B | 66.39% |
| 2019-12-31 | $0.42 B | -7.42% |
| 2018-12-31 | $0.46 B | -23.03% |
| 2017-12-31 | $0.60 B | 6.74% |
| 2016-12-31 | $0.56 B | -16.81% |
| 2015-12-31 | $0.67 B | -12.28% |
| 2014-12-31 | $0.77 B | 8.59% |
| 2013-12-31 | $0.71 B | 23.19% |
| 2012-12-31 | $0.57 B | 60.49% |
| 2011-12-31 | $0.35 B | 47.37% |
| 2010-12-31 | $0.24 B | 12.95% |
| 2009-12-31 | $0.21 B | 15.69% |
| 2008-12-31 | $0.18 B | 534.4% |
| 2007-12-31 | $29.43 M |